2025年3月25日14：00-16：00 中星联华联合AD I 举办"玩转高速ADC"线上讲堂。 课程预告 扫码参加 张琪 ADI 资深FAE经理 ADI 北方区工业市场现场应用工程师经理，2019年加入 ADI，负责北方区工业、仪器仪表、 商业航天等战略大客户技术支持与团队管理。16年射频微波与高速转换器开发与技术支持经 验。 专家介绍 深度剖析ADC/DAC应用场景和主要指标 ADI最新高速转换器产品以及应用介绍 拆解MXFE系列指标及应用场景 深入浅出讲解ADC静态参数和动态参数测试 独家解读JESD204B接口在高速ADC/DAC中测试 苏水金 中星联华技术支持总监 《测试测量加油站》公众号创始人，具有二十多年电子测试测量经验，对实时示波器、频 分析仪、模拟信号源、矢量信号源、误码仪、取样示波器、TDR、AWG、逻辑分析仪、采 记录回放仪、信道模拟器等仪器非常熟悉；并在高速信号完整性、电源完整性、半导体 试、ADC/DAC、光通信、汽车电子、仪器编程、计量校准、通信、复杂电磁环境，相控阵 线等领域的测试有深入研究。 听 ADI 资深技术大咖解析AD/DA前沿技术! 探秘 ADC与AI、自动驾驶、高速 ...

FibroGen, Inc. (NASDAQ:FGEN) Q4 2024 Earnings Conference Call March 17, 2025 5:00 PM ET Company Participants Joanne Greller - LifeSci Advisors Thane Wettig - CEO David DeLucia - CFO Conference Call Participants Andy Sieh - William Blair Matthew Keller - H.C. Wainwright Operator Hello everyone, and welcome to the FibroGen Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer s ...

Redwire Corporation (NYSE:RDW) Q4 2024 Earnings Conference Call March 11, 2025 9:00 AM ET Company Participants Jeffrey Zeunik - Senior Vice President, Financial Planning Analysis, Investor Relations Peter Cannito - Chairman, Chief Executive Officer Jonathan Baliff - Chief Financial Officer Conference Call Participants Greg Konrad - Jefferies Scott Buck - H.C. Wainwright & Co. Brian Kinstlinger - Alliance Global Partners Griffin Boss - B. Riley Securities Suji DeSilva - Roth Capital Partners Jeff Zunick Let ...

Zymeworks Inc. (NASDAQ:ZYME) Q4 2024 Earnings Conference Call March 5, 2025 4:30 PM ET Company Participants Shrinal Inamdar - Director, Investor Relations Leone Patterson - Executive Vice President, Chief Business and Financial Officer Paul Moore - Chief Scientific Officer Kenneth Galbraith - Chair and Chief Executive Officer Conference Call Participants Stephen Willey - Stifel Yigal Nochomovitz - Citi Brian Cheng - JPMorgan Jonathan Miller - Evercore ISI Jay Olson - Oppenheimer & Co. Justin Zelin - BTIG Op ...

Mersana Therapeutics (MRSN) Q4 2024 Earnings Call March 03, 2025 08:00 AM ET Company Participants Jason Fredette - Senior Vice President of Investor Relations & Corporate CommunicationsMartin Huber - President & CEOBrian DeSchuytner - Senior VP, CFO & COOPaul Jeng - Vice President Conference Call Participants Yen-Der Li - Biotech Equity Research AnalystCharles Zhu - Managing Director, Senior Biotechnology Research AnalystAndy Hsieh - Research AnalystAsthika Goonewardene - AnalystNick Quartapella - Equity Re ...

Sinclair, Inc. (NASDAQ:SBGI) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Chris King - Vice President of Investor Relations Christopher Ripley - President and Chief Executive Officer Robert Weisbord - Chief Operating Officer and President of Local Media Lucy Rutishauser - Executive Vice President and Chief Financial Officer Conference Call Participants Daniel Kurnos - Benchmark Aaron Watts - Deutsche Bank David Hamburger - Morgan Stanley Benjamin Soff - Deutsche Bank Op ...

ADC Therapeutics (ADCT) Conference February 06, 2025 02:00 PM ET Company Participants Ameet Mallik - CEO Conference Call Participants Michael Schmidt - Senior Managing Director & Equity Research Analyst - Biotechnology Michael Schmidt All right. So welcome to this next fireside chat with ADC Therapeutics. My name is Michael Schmidt, biotech analyst with Guggenheim. And with me today, I have Amit Malik, CEO of ADC And so, Amit, welcome. Thanks for joining us. Ameet Mallik Thank you. Michael Schmidt So just a ...

成立一年多来，实现了临床前到临床阶段的快速跨越。 本文为IPO早知道原创 作者｜Stone Jin 微信公众号｜ipozaozhidao 据IPO早知道消息，安领科生物（Allink Biotherapeutics）日前完成4200万美元A轮融资。本轮融 资由蓝驰创投领投，元生创投、君联资本、建发新兴投资跟投，同时获得老股东高榕创投和幂方健康 基金的追加投资。安领科生物致力于开发新一代双特异性抗体和ADC疗法，为肿瘤和免疫疾病患者 带来更优的治疗方案。 本轮融资将助力加速安领科生物的全球化布局，包括推进其核心管线ALK201和ALK202在澳大利 亚、美国和中国的I期临床研究，并积极拓展肿瘤和免疫领域的研发管线，持续优化其自主研发的双 特异性抗体和ADC技术平台，打造具有全球影响力的生物科技公司。 "公司成立一年多来，实现了临床前到临床阶段的快速跨越。"安领科生物创始人兼CEO冯辉博士表 示："在当前生物医药行业融资环境下，我们特别感谢现有股东的持续信任与支持，也很荣幸能够迎 来认可我们创新能力与执行效率的新投资伙伴。有了他们的支持，我们将能更快地推进包括新一代 ADC和双特异性抗体在内的创新管线开发，为肿瘤 ...

Allakos (ALLK) Update / Briefing January 16, 2024 08:00 AM ET Speaker0 Ladies and gentlemen, thank you for standing by. Welcome to LearnTelomob Phase II chronic spontaneous urticaria and atopic dermatitis results. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withd ...